During 2015 the patent Method for detection of cytokeratin 8, 18 and/or 19 and/or soluble fragments thereof was approved in Sweden. In September 2017 the patent was approved in China. The patent has now also been approved in Europe and is valid until 2034.
IDL Biotech continues its work on automating the TPS® tumor marker
As previously informed, at the end of 2019, IDL Biotech signed a cooperation agreement with the Chinese company Zecen Biotech, regarding automation of the tumor marker TPS® on all Zecen Biotech's instruments. The development project has proceeded very well and the...
